The interaction of Cyclosporin A with Lipoproteins
The success of transplantation has been largely attributed to the introduction of the immunosuppressant, Cyclosporin A (CsA). However, patients receiving CsA frequently become dyslipidemic and this is thought to augment the nephrotoxic and hepatotoxic effects by interfering with the distribution...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/2429/4779 |